Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Shoya Iwanami, William S. Hart, Robin N. Thompson, Il Hyo Jung, Shingo Iwami, Marco Ajelli, Kazuyuki Aihara. A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks. Communications Medicine. 2025
Shoya Iwanami, Toshiko Sato, Hiroshi Haeno, Longchen Xu, Keimyo Imamura, Jun Ooehara, Xun Lan, Hiromitsu Nakauchi, Shingo Iwami, Ryo Yamamoto. Stable platelet production via the bypass pathway explains the long-term reconstitution capacity of hematopoietic stem cells. 2024
Naotoshi Nakamura, Yurie Kobashi, Kwang Su Kim, Hyeongki Park, Yuta Tani, Yuzo Shimazu, Tianchen Zhao, Yoshitaka Nishikawa, Fumiya Omata, Moe Kawashima, et al. Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population. PLOS Digital Health. 2024
Hyeongki Park, Raiki Yoshimura, Shoya Iwanami, Kwang Su Kim, Keisuke Ejima, Naotoshi Nakamura, Kazuyuki Aihara, Yoshitsugu Miyazaki, Takashi Umeyama, Ken Miyazawa, et al. Stratification of viral shedding patterns in saliva of COVID-19 patients. 2024
Teiko Kawahigashi, Shoya Iwanami, Munetomo Takahashi, Joydeep Bhadury, Shingo Iwami, Satoshi Yamazaki. Age-related changes in the hematopoietic stem cell pool revealed via quantifying the balance of symmetric and asymmetric divisions. PLOS ONE. 2024
Quantitative evaluation of bypass pathways on the differentiation potential of hematopoietic stem cells
(13th European Conference on Mathematical and Theoretical Biology 2024)
Application of virus dynamics to the evaluation of antiviral drugs
(KSMB-SMB 2024 SEOUL 2024)
造血幹細胞の能力の定量的評価
(第8回理論免疫学ワークショップ 2024)
Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors
(Epidemics: 9th International Conference on Infectious Disease Dynamics 2023)